Assessment of methodological quality was incorporated into a levels-of-evidence scheme.
The solution to determining relative merit lies in developing a well-documented, generally accepted weight-of-evidence scheme to evaluate both peer-reviewed and GLP information used in regulatory decision making where both merit and specific relevance inform the process.
Although neither peer review nor GLP standards can fully meet the needs for data quality and relevant science on their own, the authors write, a properly devised weight-of-evidence scheme can fill those overarching requirements.
The solution lies in developing a well-documented, generally accepted weight-of-evidence scheme that is designed to compare, contrast, and evaluate both peer-reviewed and GLP information and to determine relative merit and general validity.
The observed physicochemical and functional similarity between products, as part of the totality-of-the-evidence scheme, will determine the extent of upcoming nonclinical and clinical studies, considering that it diminishes the uncertainty of exhibiting different pharmacological profiles.
A well-documented, generally accepted weight-of-evidence scheme designed to evaluate both journal peer-reviewed and GLP information for regulatory activities would also aid in updating schemes for determining relative merit and general validity in journal peer-review and GLP activities.
This would provide more transparent and effective weight-of-evidence schemes for evaluating the relative merit of toxicological studies/data for regulatory decision making.
"What is evidence of scheme or conspiracy that covers the January 18 game?
Following this, the evidence rating scheme described above was used to report the review's results against each identified outcome type.
CAK applied the evidence assessment scheme to published reviews coordinated by the Consumers and Communication Review Group and contributed to drafts.
They also include price-volume agreements (PVAs), patient access schemes where typically drugs are provided free for a period of time, 'coverage with evidence development' schemes as well as payment by result schemes based on outcomes achieved in practice.
